Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis. Kawai S, Takeshima N, Hayasaka Y, Notsu A, et al. BMC Cancer 2021;21:116.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kawai S, Takeshima N, Hayasaka Y, Notsu A, et al. Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis. BMC Cancer 2021;21:116.
PMID: 33541293